CytomX Therapeutics: Doubling Overnight On Phase 1 Data

CytomX Therapeutics (NASDAQ: CTMX ) is a biotech focused on development of novel immunotherapy approaches for different forms of cancer. In my first coverage of them, I expressed a bullish sentiment primarily onI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of in ...